FDA Import Refusal 1FX-3387421-4/10002/1 — IBSA Pharma SAS

IBSA Pharma SAS — FEI 3024048417

The FDA refused shipment 1FX-3387421-4/10002/1 from IBSA Pharma SAS (France) on Aug 19, 2026. The refused product falls under Drugs and Biologics — HYALURONIDASE. Cited charges: 118,3280,336,472,75,9999978,9999979,9999982 This firm has 1 other import refusal on record.